Investor Contact:
Chris Tyson
Managing Director
MZ Group - MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us
Sigma Labs, Inc.
Condensed Balance Sheets
(Unaudited)
| June 30, 2019 | December 31, 2018 | ||||||
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash | $ | 696,390 | $ | 1,279,782 | |||
| Accounts Receivable, net | 37,982 | 38,800 | |||||
| Note Receivable, net | 79,875 | 121,913 | |||||
| Inventory | 570,426 | 240,086 | |||||
| Prepaid Assets | 68,718 | 67,255 | |||||
| Total Current Assets | 1,453,391 | 1,747,836 | |||||
| Other Assets: | |||||||
| Property and Equipment, net | 205,538 | 277,944 | |||||
| Intangible Assets, net | 510,718 | 404,978 | |||||
| Investment in Joint Venture | 500 | 500 | |||||
| Total Other Assets | 716,756 | 683,422 | |||||
| TOTAL ASSETS | $ | 2,170,147 | $ | 2,431,258 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current Liabilities: | |||||||
| Accounts Payable | $ | 368,055 | $ | 217,488 | |||
| Notes Payable | 50,000 | 50,000 | |||||
| Deferred Revenue | 78,773 | 51,498 | |||||
| Accrued Expenses | 271,154 | 376,833 | |||||
| Total Current Liabilities | 767,982 | 695,819 | |||||
| TOTAL LIABILITIES | 767,982 | 695,819 | |||||
| Commitments & Contingencies | |||||||
| Stockholders’ Equity | |||||||
| Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding, respectively | - | - | |||||
| Common Stock, $0.001 par; 22,500,000 shares authorized; 10,937,590, and 8,776,629 issued and outstanding, respectively | 10,938 | 8,777 | |||||
| Additional Paid-In Capital | 24,243,575 | 21,501,407 | |||||
| Accumulated Deficit | (22,852,348 | ) | (19,774,745 | ) | |||
| Total Stockholders’ Equity | 1,402,165 | 1,735,439 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 2,170,147 | $ | 2,431,258 | |||
Sigma Labs, Inc.
